FDA Inspection 872311 — ImpactLife

ImpactLife — FEI 1470254

The FDA completed an inspection of ImpactLife on Mar 31, 2014 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 31, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, IL (United States)